Private Advisor Group, LLC Provention Bio, Inc. Transaction History

Private Advisor Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$3.65 - $7.3 $64,630 - $129,261	-17,707 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$3.4 - $7.88 $60,203 - $139,531	17,707 New	17,707 $129,000
Q3 2021 Oct 14, 2021	SELL	$5.66 - $8.33 $138,104 - $203,252	-24,400 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$6.71 - $11.04 $163,724 - $269,376	24,400 New	24,400 $206,000
Q4 2020 Apr 01, 2021	SELL	$11.79 - $18.94 $127,331 - $204,552	-10,800 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$10.34 - $15.2 $44,462 - $65,360	4,300 Added 66.15%	10,800 $139,000
Q2 2020 Aug 17, 2020	BUY	$7.81 - $17.0 $50,765 - $110,500	6,500 New	6,500 $92,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.